Clinical Trials Logo

Acute Recurrent Pancreatitis clinical trials

View clinical trials related to Acute Recurrent Pancreatitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT06386224 Not yet recruiting - Clinical trials for Chronic Pancreatitis

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

IMPACT-2
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Severe and disabling abdominal pain is common in individuals with chronic pancreatitis. Although pain is associated with reduced quality of life and high economic and societal costs, there are limited effective options for pain management in this population. This study proposes an evidence-based psychological intervention approach using an internet-delivered pain self-management program to minimize the impact of pain and improve quality of life. The ultimate goal is to maximize the public health impact of the intervention with successful implementation and dissemination to pancreas clinics and to the community.

NCT ID: NCT06068426 Recruiting - Clinical trials for Chronic Pancreatitis

Incorporating Endoscopic Ultrasound and Elastography Towards Improving Outcomes of Pediatric Pancreatitis Management

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

The main reason for this research study is to find out more about acute recurrent pancreatitis and chronic pancreatitis in children. There are few studies on childhood pancreatitis, so diagnosis and treatment are based on adult studies. This limits our understanding and treatment of these disorders in children. Endoscopic ultrasound (EUS) is a tool used to assess and diagnose pancreatic disease. We can use ultrasound with shear wave elastography (SWE) to measure fibrosis (scarring) of the pancreas. We can use SWE on both EUS and transabdominal ultrasound (TUS) systems. Both TUS and EUS SWE have been studied for diagnosis of chronic pancreatitis in adult patients, however they have not been studied in children. We plan to use EUS SWE and TUS SWE information in this study to help us understand pancreatitis in children. Children with pancreatitis and children without pancreatitis (controls) will be invited to participate in this study.

NCT ID: NCT04760847 Not yet recruiting - Pancreatitis Clinical Trials

Intermittent Fasting for Pancreatitis

IFPanc
Start date: May 7, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.

NCT ID: NCT03707431 Active, not recruiting - Clinical trials for Chronic Pancreatitis

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Start date: April 25, 2019
Phase: N/A
Study type: Interventional

Abdominal pain is common in children with chronic and acute recurring pancreatitis (CP, ARP), and as they continue into adulthood, the disease progresses with increased pain and greater exposure to opioids. Despite the relevancy of early pain self-management for childhood pancreatitis, there have been no studies of non-pharmacological pain intervention in this population. The proposed project will evaluate a web-based cognitive behavioral pain management program delivered to a cohort of well-phenotyped children with CP/ARP and some community participants to reduce pain, pain-related disability and enhance HRQOL; it will also identify genetic risk factors and clinical and behavioral phenotypic factors associated with treatment response to enable precision medicine approaches.

NCT ID: NCT00621283 Terminated - Clinical trials for Chronic Pancreatitis

Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population

Start date: February 2008
Phase: Phase 1
Study type: Interventional

1. To assess the effect of RG1068 at a dose of 0.2 mcg/kg intravenously (IV) on the diameter of the pancreatic duct when used during Magnetic Resonance Pancreatography. 2. To demonstrate that RG1068-enhanced MRCP improves image quality relative to unenhanced MRCP in patients with unexplained acute recurrent pancreatitis (ARP) and chronic pancreatitis. 3. To evaluate if the use of RG1068-enhanced MRCP improves structural delineation of the pancreatic duct as compared to the non-enhanced MRCP. 4. To assess pancreatic exocrine function by quantifying pancreatic fluid output into the duodenum and the apparent diffusion coefficient of the pancreas.